cardiology careers collections past issues search home
     

Correction for White et al., J Am Coll Cardiol 51 (18) 1734-1741.
J Am Coll Cardiol, 2008; 51:2197, doi:10.1016/j.jacc.2008.04.015
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager

Correction

White HD, Chew DP, Hoekstra JW, et al. Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non–ST-segment elevation acute coronary syndromes managed with an invasive strategy: Results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol 2008;51:1734–41.

In this article, the disclosures for Dr. Chadwick D. Miller were omitted. The full disclosures are below:

Dr. Miller is receiving or has received research support from Schering-Plough Research, Biosite, Millennium/Schering-Plough Research, Heartscape Inc., and Johnson & Johnson/Scios, Inc.; has received lecture fees from Genentech; and has served as a consultant to The Medicines Company, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, and Molecular Insight.





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager

 
  cardiology careers collections past issues search home